PURPOSE: For prostate cancer that is thought to be locally recurrent after prostatectomy, the
optimal timing, dose and techniques for salvage radiotherapy (SRT) have not been …

CONTEXT: Approximately 15–25% of men who undergo radical prostatectomy for localized
prostate cancer (PCa) will experience recurrence of their cancer; men with poorly …

Abstract The first ESMO Consensus Conference on prostate cancer was held in Zurich,
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …

BACKGROUND AND PURPOSE: Three randomised trials have demonstrated the benefit of
adjuvant post-prostatectomy radiotherapy (PPRT) for high risk patients. Data also …

OBJECTIVE. In patients with clinically suspected local recurrence of prostate cancer, a
lobulated hyperintense mass in the radical prostatectomy fossa can be readily visualized …

Purpose Prostate specific antigen is an important tool to monitor patients with prostate
cancer after radical prostatectomy. Ultrasensitive prostate specific antigen assays are …

Abstract Approximately 15–25% of men who undergo radical prostatectomy for localized
prostate cancer will experience a PSA-defined biochemical recurrence (BCR) of their cancer …

Radical prostatectomy (RP) is the most common primary treatment for prostate cancer. About
40% of those with high-risk pathologic features, such as a positive margin or seminal vesicle …

OBJECTIVE:: To test high-intensity focused ultrasound (HIFU) as salvage first-line treatment
for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer (CaP) after …

Objective To assess the characteristics of biochemical recurrence in the late period (> 5
years after radical prostatectomy) and the differences in the predictors of biochemical …